Keytruda 100 MG/4 ML vial 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FKKJ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,456
Award facts
- Contract value 100% obligated
- $87,455.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a $87,455.90 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. This firm fixed-price delivery order, issued on December 31, 2025, with an ultimate completion date of January 23, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was executed without subcontractor involvement, with DMS Pharmaceutical Group serving as the sole prime contractor.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent contract, valued at $499.999 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor supporting the Department of Defense's broader $30.3 billion pharmaceutical acquisition strategy. The PPV-G GEN V program authorizes the issuance of firm fixed-price delivery orders for a comprehensive portfolio of branded and generic pharmaceuticals, biologics, and medical consumables to support recurring medical supply requirements for military healthcare facilities worldwide, with this particular delivery order representing one of numerous awards issued to the contractor to fulfill the specialized pharmaceutical needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FKKJ0?
SPE2DR26FKKJ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FKKJ0 worth?
The government has obligated $87,456 on SPE2DR26FKKJ0.
Is contract SPE2DR26FKKJ0 an order under another contract?
Yes. SPE2DR26FKKJ0 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKJ0 competed?
The extent of competition for SPE2DR26FKKJ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award